SCHEMBL19567537

SCHEMBL19567537

COc1ccc(CN2CCC(C)(CC#N)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 6/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ USP2 O75604 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ KCNH2 Q12809 2/20 0.50
▸ PTGIR P43119 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ MMP1 P03956 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ MMP13 P45452 1/20 0.46
▸ ADAM17 P78536 1/20 0.46
▸ CHKA P35790 1/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24092983 0.96 CHKA (0.52) SIGMAR1SMN1; SMN2USP2CYP1A2CYP2C9
SCHEMBL20782192 0.85 SIGMAR1 (0.47) SIGMAR1SMN1; SMN2USP2TSHRKDM4E
SCHEMBL19568016 0.85 SIGMAR1 (0.52) SIGMAR1SMN1; SMN2USP2CYP1A2CYP2C9
SCHEMBL24093065 0.84 ALDH1A1 (0.58) TSHRKCNH2ALDH1A1LMNA
SCHEMBL24093035 0.84 ALDH1A1 (0.50) SIGMAR1USP2CYP1A2CYP2C9TSHR
SCHEMBL24093457 0.83 ALDH1A1 (0.44) SIGMAR1USP2ALDH1A1DRD2HTR2A
SCHEMBL19567217 0.83 USP2 (0.59) SMN1; SMN2USP2CYP1A2CYP2C9TSHR
SCHEMBL20781878 0.83 SIGMAR1 (0.50) SIGMAR1SMN1; SMN2USP2CYP1A2CYP2C9
SCHEMBL20782046 0.83 SIGMAR1 (0.50) SIGMAR1SMN1; SMN2USP2CYP1A2CYP2C9
SCHEMBL24093376 0.82 OPRM1 (0.57) SIGMAR1CYP1A2CYP2C9TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 — — WO disclosed
Send feedback